Grapefruit Usa Inc (GPFT) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket
 


Grapefruit Usa Inc   (GPFT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Grapefruit Usa Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Grapefruit Usa Inc 's ROA in the third quarter of 2022?
Grapefruit Usa Inc recorded a cumulative net loss of $-4 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -163.61%.

However, within the Healthcare sector 1081 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2022 quarter, so far to 5449, from total ROA ranking in the second quarter of 2022 at 5557.

What is ROA?



Return On Assets (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Total Assets Change -10.6 % -24.22 % -17.44 % -7.63 % 10.73 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -4 -5 -5 -6 2
Return On Assets (TTM) -163.61 % -166.96 % -155.48 % -178.36 % 72.12 %
GPFT's Total Ranking # 5449 # 5557 # 5455 # 5838 # 56
Total Assets (TTM) in million 3 2 3 3 3
Seq. Total Assets Change 13.57 % -13.24 % -2.15 % -7.27 % -3.74 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 47
Sector # 1082
Overall # 5329

Return On Assets Statistics
High Average Low
6597.08 %
-3535.23 %
-43565.85 %
(Sep 30 2014)   (Sep 30 2018)





Financial Statements
Grapefruit Usa Inc 's Assets $ 3 million GPFT's Balance sheet
Grapefruit Usa Inc 's Income $ -1 million Quarterly GPFT's Income Statement
GPFT's Income by Division See GPFT's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
Y / Y Total Assets Change -7.63 % 20.88 % 17627.91 % 295.88 % -84.15 %
Total Assets in million 3 3 3 0 0
Y / Y Net Income Change - - - - -
Net Income in million -6 -4 -5 -8 3
Annual Return On Assets -195.48 % -133.06 % -182.35 % -57141.93 % 79368.7 %




More Return On Assets Ratios
GPFT's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GPFT's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GPFT's Competitors
Subscribers only: Roa for Grapefruit Usa Inc 's Suppliers
Subscribers only: Return On Assets for GPFT's Customers

You may also want to know
GPFT's Roi GPFT's Inventory Turnover Ratio GPFT's Growth Rates GPFT's Dividend Comparisons
GPFT's Profitability Ratios GPFT's Asset Turnover Ratio GPFT's Dividend Growth
GPFT's Roe GPFT's Valuation Ratios GPFT's Financial Strength Ratios GPFT's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA


Date modified: 2026-09-08T15:10:47+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.